AI Chatbot Governance in MedTech: Balancing Safety and Speed in 2026

This episode explores the critical challenge MedTech leaders face in 2026 regarding the safe implementation of AI chatbots in healthcare. We discuss how to develop a robust governance model that effectively balances the competing demands of innovation speed, user-friendliness, essential human oversight, and uncompromising patient safety to prevent misleading patients and clinicians. - How can MedTech companies deploy AI chatbots without compromising patient safety? - What does a balanced governance model for clinical AI look like in practice? - What is the "human-in-the-loop" model and why is it essential for medical AI? - How can organizations manage the pressure to innovate quickly while ensuring rigorous validation? - What are the key regulatory and safety considerations for AI influencing care pathways? - How should usability be designed to prevent over-reliance on AI by clinicians? - What are the risks of AI "correctness drift" in a post-market setting? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access with a unique blend of local expertise and advanced AI. Our services cover the entire product lifecycle, from regulatory strategy and technical dossier submission to post-market surveillance. By leveraging AI and a network of local experts in over 30 markets, we help you navigate complex regulatory landscapes efficiently. For help getting your medical device to market faster, contact us at [email protected], visit https://pureglobal.com/, or explore our free AI tools and database at https://pureglobal.ai.